The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.
Australian women at risk of having babies suffering severe mitochondrial disease may soon be able to have healthy children.
The prestigious NHMRC Research Excellence Awards recognise recent outstanding performance in the health and medical research field.
Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.
More than 2700 stem cell scientists from 50 countries are in Melbourne for the 16th Annual Meeting of the International Society for Stem Cell Research (ISSCR).
Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.
A new haemodialysis therapy has the potential to significantly advance renal (kidney) care for patients.
The NSW Government has announced the appointment of world-renowned robotics expert Professor Hugh Durrant-Whyte as the next NSW Chief Scientist & Engineer.
The foundation has three new areas of focus: entrepreneurship in science, leadership in our schools and guiding Australia's response to complex global legal issues.
Biochemist and molecular biologist Professor John Shine AC FAA has commenced as President of the Australian Academy of Science.
As part of Vivid Sydney 2018, light projections of infectious biological agents will be expanded up to a billion times in size and beamed onto buildings in The Rocks.
The Australian Academy of Science has recognised 21 scientists for their outstanding contributions to science.
20 May is International Clinical Trials Day, highlighting the importance of clinical trials research and commemorating the first controlled clinical trial in history.
Genomics, nanotechnology, imaging, supercomputing and astronomy are some of the areas set to get a boost from the federal government's research investment strategy.